Highlights From the 2019 World Conference on Lung Cancer*

September 7-10, 2019; Barcelona, Spain
Are you aware of the latest clinical data in lung cancer? In this online CME-certified commentary, Suresh S. Ramalingam, MD, discusses key studies presented at the 2019 World Conference on Lung Cancer.
Suresh S. Ramalingam, MD


New clinical data in lung cancer are emerging with the potential to change clinical practice. In this commentary, I discuss top studies on both immunotherapies and novel targeted agents that were presented at WCLC 2019.

Suresh S. Ramalingam, MD Physicians: maximum of 0.4 AMA PRA Category 1 Credits Released: September 26, 2019 Expired: September 25, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Bristol-Myers Squibb

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?